Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
Published:
Last Updated:
The short interest data are out for the most recent settlement date, January 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, with big potential upside and big potential downside.
As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock, then some short sellers can argue for a stock implosion down the road.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Amgen Inc. (NASDAQ: AMGN) saw its short interest drop to 9.87 million shares from the previous level of 10.18 million. Shares were last seen trading at $185.79, in a 52-week range of $163.31 to $210.19.
Short interest in Biogen Inc. (NASDAQ: BIIB) decreased to 2.85 million shares from the previous 3.59 million. The stock recently traded at $316.87, within a 52-week range of $249.17 to $388.67.
Celgene Corp.’s (NASDAQ: CELG) short interest for this settlement date decreased to 15.17 million shares from the previous level of 16.14 million. Shares were changing hands at $89.87, in a 52-week trading range of $58.59 to $97.43.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest decrease to 11.55 million shares from 13.43 billion in the previous period. Shares were trading at $67.62 in a 52-week range of $60.32 to $82.72.
The number of MannKind Corp. (NASDAQ: MNKD) shares short increased to 38.81 million. The previous reading was 38.53 million. The stock was last seen at $1.33 a share, in a 52-week range of $0.94 to $3.41.
Alexion Pharmaceuticals Inc.’s (NASDAQ: ALXN) short interest increased to 4.32 million shares from the previous 3.67 million. Shares were trading at $120.05, in a 52-week range of $92.56 to $140.77.
The Average American Has No Idea How Much Money You Can Make Today (Sponsor)
The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.
But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.